p1

Cambridge Healthtech Institute’s 22nd Annual

Recombinant Protein Expression and Production

January 21-22, 2020

Part of the Biotherapeutic Expression & Production pipeline

 

Great strides have been made in the expression, production, and purification of biotherapeutics. However, hurdles remain to improving the quantity and quality of the efficient expression and production of these valuable biomolecules while minimizing time and cost. There is a greater demand for higher-throughput expression and purification, as well as more flexible expression platforms. Unfortunately, there is no “universal” production system which can guarantee high yields of recombinant protein, particularly as every biomolecule causes issues in terms of its own expression.

Cambridge Healthtech Institute’s 22nd Annual Recombinant Protein Expression and Production conference explores the newest data and innovations for the best choices in hosts/systems, as well as ways to “rescue” existing systems and make them work more effectively to improve the quality and quantity of the desired biotherapeutic.

 

Coverage will include, but is not limited to:

  • Cell Factories
    • Mammalian (CHO, HEK293, NS0)
    • Insect (Baculovirus, Drosophila)
    • Bacterial (Escherichia coli)
    • Yeast (Pichia pastoris, Saccharomyces cerevisiae)
    • Other (Algae, Tobacco)
  • Host Selection
  • Cloning Strategies
    • Biotherapeutic Proteins
    • Recombinant Proteins
    • Antibodies
    • Vaccines
    • VLPs
    • Vectors
    • Membrane Proteins
    • Difficult-to-Express Proteins
  • Matching Host to Protein of Choice
  • Re - Engineering Existing Systems for Better Performance
  • Automation for Higher Throughput
  • Faster Turnaround Times
  • Increasing Speed and Lowering Cost
  • Case Studies

 

* The program is subject to change without notice, due to unforeseen reason.







2020 Conferences & Training Seminars